Malondialdehyde and carbonyl contents in the erthrocytes of streptozotocin-induced diabetic rats

International Journal of Diabetes and Metabolism

Volumn 13, Issue 2, 2005, Pages 96-98

  Qujeq, Durdi ^a   Habibinudeh, Masomeh ^a   Daylmkatoli, Hamideh ^a   Rezvani, Timur ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Carbonyl; Diabetes; Malondialdehyde

Indexed keywords

CARBONYL DERIVATIVE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; LIPID PEROXIDATION; MALE; MEMBRANE DAMAGE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RAT; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES;

EID: 29744462195     PISSN: 16067754     EISSN: None     Source Type: Journal    
DOI: 10.1159/000497578     Document Type: Article

References (15)

1. Cederberg J, Basu S, Eriksson UJ. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia 2001; 44: 766-774.
2. Perez-Gomez C, Segura JM, Blanca M, et al. Antioxidant activity levels and oxidative stress as blood markers of allergic response to drugs. Biochem Cell Biol 2000; 78: 691-698.
3. Kirkova M, Ivancheva E, Russannova E. Lipid peroxidation and antioxidant enzyme activity in aspirin-treated rats. Gen Pharmacol 1995; 26: 613-617.
4. Mates JM, Perez-Gomez C, Olalla L, et al. Allergy to drugs: antioxidant enzymic activities, lipid peroxidation and protein oxidative damage in human blood. Cell Biochem Funct. 2000; 18: 77-84.
5. Pey A, Saborido A, Blazquez I, et al. Effects of prolonged stanozolol treatment on antioxidant enzyme activities, oxidative stress markers, and heat shock protein HSP72 levels in rat liver. J Steroid Biochem Mol Biol 2003; 87: 269-77.
6. Unlucerci Y, Bekpinar S, Kocak H. Testis glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase activities in aminoguanidine-treated diabetic rats. Arch Biochem Biophys 2000; 379: 217-220.
7. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003; 34: 1563-1574.
8. Jang YY, Song JH, Shin YK, et al. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacol Res 2000; 42: 361-371.
9. Bhor VM, Raghuram N, Sivakami S. Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocin-induced diabetic rats. Int J Biochem Cell Biol 2004; 36: 89-97.
10. Miyata T, Sugiyama S, Suzuki D, et al. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy. Kidney Int Suppl. 1999;71:S54-56.
11. Altomare E, Grattagliano I, Vendemaile G, et al. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur J Clin Invest 1997; 27: 141-147.
12. Grattagliano I, Vendemiale G, Boscia F, et al. Oxidative retinal products and ocular damages in diabetic patients. Free Radic Biol Med 1998; 25: 369-372.
13. Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989; 38: 1539-1543.
14. Gallou G, Ruelland A, Legras B, et al. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993; 214: 227-234.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 256-257.